BackSonoma Pharmaceuticals Overview

Sonoma Pharmaceuticals Operating Income

Operating Income for SNOA.

Quarterly Operating Income

$-678000.00
↓ 34.24% YoY

As of Dec 31, 2025

Annual Operating Income (TTM)

$-2766000.00
↓ 38.02% YoY

Trailing 12 months ending Dec 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin